A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virogin Biotech Ltd.
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Sichuan Cancer Hospital and Research Institute
Sir Run Run Shaw Hospital
Memorial Sloan Kettering Cancer Center
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
National Institutes of Health Clinical Center (CC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University Hospital, Bordeaux
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
West China Hospital
Hoffmann-La Roche
Yale University
Eisai Inc.
Tianjin Medical University Cancer Institute and Hospital
Ohio State University Comprehensive Cancer Center
Seagen Inc.
National Institutes of Health Clinical Center (CC)
University of Kansas Medical Center
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Stanford University
Memorial Sloan Kettering Cancer Center
University of Kentucky
Oslo University Hospital
Peking University
Big Ten Cancer Research Consortium
SOFIE
Sun Yat-sen University